Contribution of polymorphisms in the apolipoprotein AI-CIII-AIV cluster to hyperlipidaemia in patients with gout

Abstract

Background: Studies have shown that hyperuricaemia is independently related to the insulin resistance syndrome and that polymorphisms of the apolipoprotein AI-CIII-AIV cluster are also related to insulin resistance. Objective: To study the prevalence of polymorphisms of the apolipoprotein AI-CIII-AIV cluster in persons with gout and to determine whether these polymorphisms contribute to the pathophysiology of gout or to altered lipid concentrations. Methods: Plasma cholesterol, triglycerides, uric acid, VLDL, LDL, IDL, and HDL triglycerides, cholesterol, and the renal excretion of uric acid were measured in 68 patients with gout with gout and 165 healthy subjects. Polymorphisms were studied by amplification and RFLP in all subjects, using XmnI and MspI in the apolipoprotein AI gene and SstI in the apolipoprotein CIII gene. Results: The A allele at position 275 bp in the apolipoprotein AI gene was more common in patients with gout than in controls (p = 0.01). Levels of cholesterol, triglycerides, uric acid, basal glycaemia, and HDL cholesterol were higher in the patients (p,0.001). In the patients there was also an interaction between mutations at the two polymorphic loci studied in the apolipoprotein AI gene (p = 0.04). An absence of the mutation at position 275 bp of the apolipoprotein AI gene resulted in increased plasma triglyceride levels. Conclusions: Gouty patients have an altered allelic distribution in the apolipoprotein AI-CIII-AIV cluster, which could lead to changes in levels of lipoproteins. This is not caused by a single mutation but rather by a combination of different mutations.

Hyperuricemia and associated factors: a cross-sectional study of Japanese-Brazilians

“…According to the current study's data, hyperuricemia and hypertriglyceridemia are positively associated with each other. This relationship is still not totally clear in the literature, but there is purportedly a reduced renal excretion of uric acid in individuals with hyperuricemia and dyslipidemia 41 . Other studies have also shown a positive association between hypertriglyceridemia and hyperuricemia 37,38,39,41 .…”

Risk of Bias in Systematic Reviews of Non-Randomized Studies of Adverse Cardiovascular Effects of Thiazolidinediones and Cyclooxygenase-2 Inhibitors: Application of a New Cochrane Risk of Bias Tool

“…For reports with multiple risk estimates (for a single outcome), the results cited in the original systematic review were extracted and their corresponding properties were assessed (combination of variables in the statistical model, exposure definition, etc.). Two study reports in the form of abstracts [ 21 , 22 ] were excluded, as they did not contain enough information to be assessed by the instrument. This left 37 articles to be evaluated.…”

Gypenosides Inhibits Xanthine Oxidoreductase and Ameliorates Urate Excretion in Hyperuricemic Rats Induced by High Cholesterol and High Fat Food (Lipid Emulsion)

“…Recent studies have shown that orally feeding animals with LE for a period of time can raise their cholesterol, increase production of low density lipoprotein cholesterol (LDL-C) and promote the de novo synthesis of purine nucleotide from ribose 5-phosphate to 5-phosphoribosyl pyrophosphate via the common metabolic pathway of NADP-NADPH. This will eventually lead to increased generation of uric acid while its excretion is decreased [ 27 , 28 ]. Another study found that high cholesterol levels can also cause oxidative stress, and oxidative stress can promote the feed-forward loop of uric acid production, which ultimately leads to elevated serum uric acid levels [ 29 ].…”